Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Benzing

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Kidney International|March 14, 2018
Single-nephron proteomes connect morphology and function in proteinuric kidney diseaseMartin Höhne, Christian K Frese, Florian Grahammer, et al.
Nature Metabolism|July 23, 2020
A molecular mechanism explaining albuminuria in kidney diseaseLinus Butt, David Unnersjö-Jess, Martin Höhne, et al.
Kidney International|December 8, 2018
The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injuryMartin R Späth, Malte P Bartram, Nicolàs Palacio-Escat, et al.
Npj Aging|May 28, 2026
An in-depth analysis of the molecular changes induced by short-term calorie restriction before living kidney donationMartin R Späth, Sita Arjune, Katrin Bohl, et al.
Nature Communications|July 14, 2022
Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertensionMarkus M Rinschen, Oleg Palygin, Ashraf El-Meanawy, et al.
American Journal of Human Genetics|March 29, 2008
Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasiaCarsten Bergmann, Manfred Fliegauf, Nadina Ortiz Brüchle, et al.
Blood Advances|November 13, 2020
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myelomaTiziana Bruno, Francesca De Nicola, Giacomo Corleone, et al.
The EMBO Journal|August 23, 2012
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosisKatja Höpker, Henning Hagmann, Safiya Khurshid, et al.
Nature Medicine|April 27, 2026
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trialRavi Thadhani, Thomas F Hiemstra, Manu Vatish, et al.
The New England Journal of Medicine|April 28, 2016
Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 MutationsKamel Laghmani, Bodo B Beck, Sung-Sen Yang, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Kidney International|March 14, 2018
Single-nephron proteomes connect morphology and function in proteinuric kidney diseaseMartin Höhne, Christian K Frese, Florian Grahammer, et al.
Nature Metabolism|July 23, 2020
A molecular mechanism explaining albuminuria in kidney diseaseLinus Butt, David Unnersjö-Jess, Martin Höhne, et al.
Kidney International|December 8, 2018
The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injuryMartin R Späth, Malte P Bartram, Nicolàs Palacio-Escat, et al.
Npj Aging|May 28, 2026
An in-depth analysis of the molecular changes induced by short-term calorie restriction before living kidney donationMartin R Späth, Sita Arjune, Katrin Bohl, et al.
Nature Communications|July 14, 2022
Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertensionMarkus M Rinschen, Oleg Palygin, Ashraf El-Meanawy, et al.
American Journal of Human Genetics|March 29, 2008
Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasiaCarsten Bergmann, Manfred Fliegauf, Nadina Ortiz Brüchle, et al.
Blood Advances|November 13, 2020
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myelomaTiziana Bruno, Francesca De Nicola, Giacomo Corleone, et al.
The EMBO Journal|August 23, 2012
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosisKatja Höpker, Henning Hagmann, Safiya Khurshid, et al.
Nature Medicine|April 27, 2026
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trialRavi Thadhani, Thomas F Hiemstra, Manu Vatish, et al.
The New England Journal of Medicine|April 28, 2016
Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 MutationsKamel Laghmani, Bodo B Beck, Sung-Sen Yang, et al.
Pageof 27